80岁以上患者初次反式肩关节置换术的生存率与结局
本研究回顾性分析了2004至2013年间242例80岁以上患者(平均83.3岁)的初次反式肩关节置换术。结果显示90天内死亡率0.4%,医疗并发症3%,手术并发症12%,假体生存率2年98.9%、5年98.3%。结论认为年龄本身不应是禁忌症,但需仔细评估合并症。
要点
- 80岁以上患者初次RSA的90天死亡率仅0.4%,医疗并发症3%。
- 手术并发症发生率12%,外周血管疾病与并发症率升高相关。
- 假体生存率2年98.9%、5年98.3%,无松动生存率99.5%。
核心结论
- 对于80岁以上患者,初次反式肩关节置换术安全有效,医疗和手术并发症率相对较低。
- 年龄本身不应成为80岁以上患者行初次反式肩关节置换术的禁忌症,但需仔细评估合并症。
研究设计与样本
- 回顾性研究,纳入2004至2013年间242例80岁以上(平均83.3岁,标准差3.1)连续初次反式肩关节置换术患者。
- 179例完成至少2年随访或至翻修手术,用于分析生存率、疼痛、活动度和力量;全部242例用于分析90天、1年及总体死亡率、医疗并发症、手术并发症和再手术。
主要发现
- 90天内死亡1例(0.4%),末次随访时已知死亡45例(19%),中位死亡时间为术后67.7个月(四分位距40.4至94.7)。
- 医疗并发症发生于6例(3%),手术并发症发生于21/179例(12%)。
- 无翻修生存率2年为98.9%,5年为98.3%;末次随访时无松动生存率为99.5%。
- 外周血管疾病的存在与更高的并发症率相关。
临床怎么用
- 在考虑对80岁以上患者行初次反式肩关节置换术时,应仔细评估合并症,尤其是外周血管疾病。
- 年龄本身不应作为拒绝手术的唯一理由。
局限性
- 回顾性研究设计。
- 53例在2年前失访,10例在术后2年内死亡,可能影响生存率分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Reverse shoulder arthroplasty (RSA) reliably improves shoulder pain and function for a variety of indications. However, the safety and efficacy of RSA in elderly patients is largely unknown. The purpose of this study was to report the mortality, morbidity, complications, reoperations, and outcomes of primary RSA in patients aged > 80 years. PATIENTS AND METHODS: Between 2004 and 2013, 242 consecutive primary RSAs were performed in patients aged > 80 years (mean 83.3 years (sd 3.1)). Of these, 53 were lost to follow-up before two years and ten had died within two years of surgery, leaving 179 for analysis of survivorship, pain, motion, and strength at a minimum of two years or until revision surgery. All 242 patients were considered for the analysis of 90-day, one-year, and overall mortality, medical complications (90-day and overall), surgical complications, and reoperations. The indications for surgery included rotator cuff arthropathy, osteoarthritis, fracture, the sequela of trauma, avascular necrosis, and rheumatoid arthritis. A retrospective review of the medical records was performed to collect all variables. Survivorship free of revision surgery was calculated at two and five years. RESULTS: One patient (0.4%) died within the first 90 days. A total of 45 patients (19%) were known to have died at the time of the final follow-up, with a median time to death of 67.7 months (interquartile range 40.4 to 94.7) postoperatively. Medical complications occurred in six patients (3%) and surgical complications occurred in 21/179 patients (12%). Survivorship free from revision was 98.9% at two years and 98.3% at five years; survivorship free from loosening was 99.5% at final follow-up. The presence of peripheral vascular disease correlated with a higher complication rate. CONCLUSION: Primary RSA was safe and effective in patients aged > 80 years, with a relatively low rate of medical and surgical complications. Thus, age alone should not be a contraindication to primary RSA in patients aged > 80 years. However, a careful evaluation of comorbidities is required in this age group when considering primary RSA. Cite this article: Bone Joint J 2019;101-B:1520-1525.
引用
- Clark NJ, Samuelsen BT, Alentorn-Geli E, et al. Primary reverse shoulder arthroplasty in patients older than 80 years of age: survival and outcomes. Bone Joint J. 2019. PMID: 31787000. doi:10.1302/0301-620X.101B12.BJJ-2018-1571.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。